Advancing hepatocyte-based therapies: A translational perspective
Authors:
Open Access
- 7 May 2026
- journal article
- review article
- Published by Elsevier in Cell Stem Cell
- Vol. 33 (5) , 726-746
Abstract
No abstract availableKeywords
Funding Information
- Science and Technology Commission of Shanghai Municipality (25J32800100)
- National Science and Technology Major Project (2024ZD0525404)
- National Natural Science Foundation of China (32400606)
- Chinese Academy of Sciences (XDB1150000)
This publication has 188 references indexed in Scilit:
- Etanercept blocks inflammatory responses orchestrated by TNF-α to promote transplanted cell engraftment and proliferation in rat liverHepatology, 2014
- Endothelin-1 receptor A blocker darusentan decreases hepatic changes and improves liver repopulation after cell transplantation in ratsHepatology, 2013
- Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in miceHepatology, 2013
- Directly acting drugs prostacyclin or nitroglycerine and endothelin receptor blocker bosentan improve cell engraftment in rodent liverHepatology, 2012
- Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration, and functionHepatology, 2011
- The stable repression of mesenchymal program is required for hepatocyte identity: A novel role for hepatocyte nuclear factor 4αHepatology, 2011
- Hepatic irradiation augments engraftment of donor cells following hepatocyte transplantation†Hepatology, 2008
- Hepatocyte transplantation and drug-induced perturbations in liver cell compartmentsHepatology, 2007
- Hepatic precursors derived from murine embryonic stem cells contribute to regeneration of injured liverHepatology, 2006
- Multiple cell cycles occur in rat hepatocytes cultured in the presence of nicotinamide and epidermal growth factorHepatology, 1991